Lessee, Operating Lease, Liability, to be Paid, Year Four of HAEMONETICS CORP from 29 Jun 2019 to 29 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
HAEMONETICS CORP quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 29 Jun 2019 to 29 Mar 2025.
  • HAEMONETICS CORP Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 29 Mar 2025 was $7,604,000, a 20% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,604,000 -$1,849,000 -20% 29 Mar 2025 10-K 21 May 2025 2025 FY
Q1 2024 $9,453,000 +$380,000 +4.2% 30 Mar 2024 10-K 20 May 2024 2024 FY
Q1 2023 $9,073,000 +$2,078,000 +30% 01 Apr 2023 10-K 22 May 2023 2023 FY
Q1 2022 $6,995,000 -$342,000 -4.7% 02 Apr 2022 10-K 25 May 2022 2022 FY
Q1 2021 $7,337,000 +$1,644,000 +29% 03 Apr 2021 10-K 26 May 2021 2021 FY
Q1 2020 $5,693,000 28 Mar 2020 10-K 20 May 2020 2020 FY
Q4 2019 $7,422,000 28 Dec 2019 10-Q 04 Feb 2020 2020 Q3
Q3 2019 $3,284,000 28 Sep 2019 10-Q 01 Nov 2019 2020 Q2
Q2 2019 $3,288,000 29 Jun 2019 10-Q 06 Aug 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.